Distribution and elimination characteristics of 111In-DTPA-D-Phe1-octreotide and 111In-DTPA-L-Phe1-octreotide in rats

被引:10
|
作者
Laznickova, A [1 ]
Laznicek, M
Trejtnar, F
Melicharova, L
Suzuki, KH
Akizawa, H
Arano, Y
Yokoyama, A
机构
[1] Charles Univ, Fac Pharm, Res Ctr, Hradec Kralove 50005, Czech Republic
[2] Kyoto Univ, Fac Pharmaceut Sci, Sakyo Ku, Kyoto, Japan
关键词
In-111; DTPA-D-Phe(1)-octreotide; DTPA-L-Phe(1)-octreotide; biodistribution; bioelimination;
D O I
10.1007/BF03190403
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study compares distribution and elimination characteristics of In-111-DTPA-D-Phe(1)-octreotide and In-111-DTPA-L-Phe(1)-octreotide in rats and evaluated the effect of the replacement of the terminal L-phenylalanine by D-phenylalanine on pharmacokinetic profiles of the radiolabelled peptides. Both agents exhibited rapid radioactivity clearance from the blood and most organs and tissues with no systematic and significant differences in activity accumulation. The long-term retention and high radioactivity concentrations for both compounds under study were found in the kidneys and organs with a high density of somatostatin receptors, such as the pancreas and adrenals. The residence times in these organs were longer for In-111-DTPA-D-Phe(1)-octreotide in comparison with In-111-DTPA-L-Phe(1)-octreotide. The major elimination pathway for both radiolabelled peptides was relatively rapid excretion into the urine. Analysis of the renal handling by an employment of the perfused rat kidney showed that both peptides were eliminated mainly by the mechanism of glomerular filtration. Rat liver perfusion experiments confirmed a very low value of bile clearance of radioactivity for both agents under study.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [31] INVIVO APPLICATION OF [IN-111-DTPA-D-PHE1]-OCTREOTIDE FOR DETECTION OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS IN RATS
    BAKKER, WH
    KRENNING, EP
    REUBI, JC
    BREEMAN, WAP
    SETYONOHAN, B
    DEJONG, M
    KOOIJ, PPM
    BRUNS, C
    VANHAGEN, PM
    MARBACH, P
    VISSER, TJ
    PLESS, J
    LAMBERTS, SWJ
    LIFE SCIENCES, 1991, 49 (22) : 1593 - 1601
  • [32] Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide:: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide
    Decristoforo, C
    Cholewinski, W
    Donnemiller, E
    Riccabona, G
    Moncayo, R
    Mather, SJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) : 1580 - 1580
  • [33] Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-d-Phe1-octreotide
    M. Bangard
    M. Béhé
    S. Guhlke
    R. Otte
    H. Bender
    H. R. Maecke
    H. J. Biersack
    European Journal of Nuclear Medicine, 2000, 27 : 628 - 637
  • [34] Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide:: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide
    Bangard, M
    Béhé, M
    Guhlke, S
    Otte, R
    Bender, H
    Maecke, HR
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (06) : 628 - 637
  • [35] Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors
    Janson, ET
    Westlin, JE
    Öhrvall, U
    Öberg, K
    Lukinius, A
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (09) : 1514 - 1518
  • [36] Treatment of patients with neuroendocrine tumors with [111In-DTPA-D-Phe]-octreotide -: The Uppsala experience
    Janson, ET
    Garske, U
    Westlin, JE
    Welin, S
    Örlefors, H
    Granberg, D
    Skogseid, B
    Eriksson, B
    Öberg, K
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 294 - 295
  • [37] Peptide receptor radionuclide therapy with [indium-111-DTPA-D-PHE]-octreotide (OC).
    Krenning, EP
    Valkema, R
    Kooij, PPM
    Breeman, WAP
    Bakker, WH
    deHerder, WW
    vanEijck, CHJ
    Kwekkeboom, DJ
    deJong, M
    Pauwels, S
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 167 - 167
  • [38] Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases
    Georgios S. Limouris
    Achilles Chatziioannou
    Dimitrios Kontogeorgakos
    Dimitrios Mourikis
    Maria Lyra
    Panagiotis Dimitriou
    Anastasia Stavraka
    Athanassios Gouliamos
    Lambros Vlahos
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1827 - 1837
  • [39] Restaging breast cancer after somatostatin receptor scintigraphy with [In-111-DTPA-Phe-1]-octreotide
    Giannakenas, C
    Tzorakoleftherakis, E
    Kalofonos, HP
    Petsas, T
    Vassilakos, PJ
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 219 - 219
  • [40] Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases
    Limouris, Georgios S.
    Chatziioannou, Achilles
    Kontogeorgakos, Dimitrios
    Mourikis, Dimitrios
    Lyra, Maria
    Dimitriou, Panagiotis
    Stavraka, Anastasia
    Gouliamos, Athanassios
    Vlahos, Lambros
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1827 - 1837